Skip Navigation

European Heart Journal 1989 10(7):591-601;
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by BORGGREFE, M.
Right arrow Articles by MARTINEZ-RUBIO, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BORGGREFE, M.
Right arrow Articles by MARTINEZ-RUBIO, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Catheter ablation of ventricular tachycardia using defibrillator pulses: electrophysiological findings and long-term results

M. BORGGREFE*, G. BREITHARDT*, A. PODCZECK{dagger}, D. ROHNER{dagger}, T. BUDDE* and A. MARTINEZ-RUBIO*

*Department of Internal Medicine C, Hospital of the University of Munster Münster
{dagger}Department of Cardiology, Pneumology and Angiology, Hospital of the University of Düsseldorf Düsseldorf F.R.G.

Received 27 August 1987; revised 20 December 1988; .

Address for correspondence: Dr M. Borggrefe, Medizinische Klinik und Poliklinik, Innere Medizin C (Kardiologie, Angiologie). Universität Münster, Albert Schweitzer-Strasse 33, D-4400 Münster, F.R.G.

Abstract

Catheter ablation of ventricular tachycardia (VT) was attempted in 24 patients (mean age 49 ± 15·1 years) with a history of recurrent sustained VT resistant to previous antiarrhythmic drug therapy. 14 patients (58·3%) had also failed to respond to long-term administration of amiodarone alone and in combination with class I antiarrhythmic drugs. Endocardial catheter mapping during induced or spontaneous VT and/or pace-mapping were performed to identify the site of origin of VT. Direct-current high-energy anodal shocks were delivered from a conventional cardioverter with stored energies of 100, 200 or 400 J via the distal electrode of conventional catheters.

A total of 139 shocks was delivered during the first ablation procedure. One patient died from wall perforation. Within 1 week of ablation, nine patients developed spontaneous recurrences of monomorphic sustained VT, identical to the clinical VT, and one patient developeda VT with a new morphology. In addition, four patients had a recurrence of their clinical VT after several weeks. In seven of 14 patients with spontaneous recurrences after the first ablation procedure and in three patients in whom VT was again inducible at the end of the first week, a second ablation procedure was performed. One patient with inducible VT after the first and second ablation sessions was given a third ablation procedure, and was discharged from hospital on antiarrhythmic drugs which were successful despite being previously ineffective. After a mean follow-up period of 14·1 ±9·1 months, there were no spontaneous recurrences of sustained VT in 17 patients (71%) (nine without antiarrhythmic drugs and eight on antiarrhythmic drugs). In the remaining patients, incessant non-sustained VT (n = 2) or recurrent sustained VT (n = 2) occurred, and two patients died suddenly (at 2 and 21 months). There was no correlation between catheter mapping data or the results of pre-discharge electrophysiological study and clinical outcome during long-term follow-up. Complications related to catheter ablation included pulmonary oedema, cardiac tamponade, femoral artery occlusion, multiple episodes of ventricular tachycardia/fibrillation and thrombus formation, each in one patient (major complications; n = 7,29·1%), as well as transient third degree AV block, transient right or left bundle branch block, transient marked ST elevation or transient atrial tachycardia (minor complications; n = 8, 33·3%). The results suggest that catheter ablation might become an effective procedure for the non-pharmacological treatment of sustained VT. However, major improvements in technology are necessary to obtain a more long-lasting and more predictable effect, as well as to reduce ablation-related complications.

Key Words: Ventricular tachycardia • catheter ablation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
C. Wolpert, H. Pitschner, and M. Borggrefe
Evolution of ablation techniques: from WPW to complex arrhythmias
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I116 - I121.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Globits, G. Kreiner, H. Frank, G. Heinz, U. Klaar, B. Frey, and H. Gossinger
Significance of Morphological Abnormalities Detected by MRI in Patients Undergoing Successful Ablation of Right Ventricular Outflow Tract Tachycardia
Circulation, October 21, 1997; 96(8): 2633 - 2640.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. L. Mickleborough, S. Mizuno, A. Usui, G. Wilson, D. McComb, and G. Gray
Balloon electric shock ablation--A surgical technique for treatment of ventricular tachycardia: Influence of endocardial scar on depth of ablation achieved
J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 855 - 861.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.